Jean Hunleth,Sarah Burack,Lindsey Kaufman et al.
Jean Hunleth et al.
An integral part of understanding and then designing programs to reduce childhood cancer inequities includes adequate representation of people with cancer in research, including children. A scoping review was carried out to understand how c...
Neimar de Paula Silva,Andrea Gini,Anastasia Dolya et al.
Neimar de Paula Silva et al.
Childhood cancer survivors (CCS) require specialized follow-up throughout their lifespan to prevent or manage late effects of cancer treatment. Knowing the size and structure of the population of CCS is crucial to plan interventions. In thi...
Maternal autoimmune disease and its association with childhood cancer: A population-based case-control study in Denmark [0.03%]
母亲自身免疫性疾病与儿童期癌症的关联性研究：来自丹麦的人群病例对照研究
Helen T Orimoloye,Nicholas Nguyen,Chuanjie Deng et al.
Helen T Orimoloye et al.
Background: Autoimmune diseases have been linked to an increased risk of pregnancy-related complications. A family history of autoimmune diseases may be related to the risk of childhood cancer based on similar histocompat...
Palliative care services in paediatric oncology centres across Europe: A cross-sectional survey [0.03%]
欧洲儿科肿瘤中心的姑息治疗服务：一项横断面调查
Eddy Carolina Pedraza,Peter Francis Raguindin,Manya Jerina Hendriks et al.
Eddy Carolina Pedraza et al.
Background: Palliative care (PC) is an integral part of cancer treatment. However, data on service availability is limited in childhood cancers. Aim: ...
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades [0.03%]
二十多年来，患有神经母细胞瘤的患者在风险和生存率上的种族和民族差异的持续存在
Mohansrinivas Chennakesavalu,Caileigh Pudela,Mark A Applebaum et al.
Mohansrinivas Chennakesavalu et al.
Background: Racial/ethnic survival disparities in neuroblastoma were first reported more than a decade ago. We sought to investigate if these disparities have persisted with current era therapy. ...
Qi Yan,Di He,Douglas I Walker et al.
Qi Yan et al.
Background: Retinoblastoma is rare but nevertheless the most common pediatric eye cancer that occurs in children under age 5. High-resolution metabolomics (HRM) is a powerful analytical approach to profile metabolic featu...
Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy [0.03%]
PEG-asparagin酶过敏的儿童接种基于mRNA的COVID-19疫苗的安全性
Nancy Broos,Leiah J Brigitha,Annemieke Schuurhof et al.
Nancy Broos et al.
Background: Children treated for a malignancy are at risk to develop serious illness from a COVID-19 infection. Pegylated E. coli asparaginase (PEG-asparaginase) is used in the treatment of acute lymphoblastic leukemia. A...
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective [0.03%]
儿童肿瘤小组视角下的罕见肿瘤治疗：机遇与挑战
Kris Ann P Schultz,Murali Chintagumpala,Jin Piao et al.
Kris Ann P Schultz et al.
While all childhood cancers are rare, tumors that are particularly infrequent or underrepresented within pediatrics are studied under the umbrella of the Children's Oncology Group Rare Tumor committee, divided into the Retinoblastoma and In...